Divestments

Aldevron

The leading global supplier of plasmid DNA used in cell and gene therapies

Aldevron is the leading global supplier of GMP, GMP-SourceTM and Research Grade plasmid DNA used in commercial, clinical and research stage gene therapies, as well as proteins, antibodies and mRNA.

  • Sector
    Healthcare
  • Country
    United States
  • Responsible Advisor
    Eric Liu
  • Fund
    EQT VIII
  • Entry
    2019
  • Web
  • Exit
    2021-08-30
  • Societal Contribution

  • 3Good health and well-being
  • 9Industry, innovation and infrastructure
  • 12Responsible consumption and production

About Aldevron
Founded in 1998 by Michael Chambers and John Ballantyne, Aldevron is the leading global supplier of GMP, GMP-SourceTM and Research Grade plasmid DNA used in commercial, clinical and research stage gene therapies, as well as proteins, antibodies and mRNA. The company’s mission is to develop and manufacture biologics at the highest quality that help make meaningful changes worldwide, and its custom development and manufacturing capabilities enable scientists to develop groundbreaking new therapies. Aldevron is based in Fargo, North Dakota and has additional operations in Madison, Wisconsin and Freiburg, Germany. The Company serves leading academic and research institutions, pharmaceutical and biotechnology companies.

Subscribe for the latest updates

Subscribe to EQT's press releases, regulatory press releases and updates.

Type of news
Preferred language
EQT logo
A purpose-driven global investment organization
© EQT AB 2021. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180